Abstract

Genome-wide association studies have linked gene variants of the receptor patched homolog 1 (PTCH1) with chronic obstructive pulmonary disease (COPD). However, its biological role in the disease is unclear. Our objective was to determine the expression pattern and biological role of PTCH1 in the lungs of patients with COPD. Airway epithelial-specific PTCH1 protein expression and epithelial morphology were assessed in lung tissues of control and COPD patients. PTCH1 mRNA expression was measured in bronchial epithelial cells obtained from individuals with and without COPD. The effects of PTCH1 siRNA knockdown on epithelial repair and mucous expression were evaluated using human epithelial cell lines. Ptch1+/− mice were used to assess the effect of decreased PTCH1 on mucous expression and airway epithelial phenotypes. Airway epithelial-specific PTCH1 protein expression was significantly increased in subjects with COPD compared to controls, and its expression was associated with total airway epithelial cell count and thickness. PTCH1 knockdown attenuated wound closure and mucous expression in airway epithelial cell lines. Ptch1+/− mice had reduced mucous expression compared to wildtype mice following mucous induction. PTCH1 protein is up-regulated in COPD airway epithelium and may upregulate mucous expression. PTCH1 provides a novel target to reduce chronic bronchitis in COPD patients.

Details

Title
Hedgehog signaling in the airway epithelium of patients with chronic obstructive pulmonary disease
Author
Tam, A 1 ; Hughes, M 2   VIAFID ORCID Logo  ; McNagny, K M 2   VIAFID ORCID Logo  ; Obeidat, M 1   VIAFID ORCID Logo  ; Hackett, T L 3 ; Leung, J M 1 ; Shaipanich, T 4 ; Dorscheid, D R 1 ; Singhera, G K 1 ; Yang C W T 1   VIAFID ORCID Logo  ; Paré, P D 1 ; Hogg, J C 1 ; Nickle, D 5 ; Sin, D D 1   VIAFID ORCID Logo 

 St. Paul’s Hospital, Center for Heart Lung Innovation, Vancouver, Canada (GRID:grid.416553.0) (ISNI:0000 0000 8589 2327) 
 University of British Columbia, Biomedical Research Centre (BRC), Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 St. Paul’s Hospital, Center for Heart Lung Innovation, Vancouver, Canada (GRID:grid.416553.0) (ISNI:0000 0000 8589 2327); University of British Columbia, Department of Anaesthesiology, Pharmacology, & Therapeutics, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 University of British Columbia, Division of Respiratory Medicine, Department of Medicine, St. Paul’s Hospital, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 Merck & Co. Inc., Rahway, United States of America (GRID:grid.417993.1) (ISNI:0000 0001 2260 0793) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2187939501
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.